AVTOZMA
Live / Registered — Registered (as of 04 Jun 2024)
What this means for you
Registered since 04 Jun 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79366724
- Registration number
- 7404207
- Mark type
- Stylized text
- Filed
- 06 Mar 2023
- Published for opposition
- 12 Mar 2024
- Registered
- 04 Jun 2024
- Attorney of record
- Max Vern
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, immunosuppressants, pharmaceutical preparations for the treatment of COVID-19, and anti-interleukin-6 (il-6) receptor monoclonal antibody for the treatment of disease caused by il-6 production; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for suppressing cytokine; pharmaceutical preparations for the treatment of arteritis; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for immunity adjustment; monoclonal antibodies for medical purposes; pharmaceutical preparations for the treatment of auto-immune diseases
Owner
- CELLTRION, INC., KR
- CELLTRION, INC., KR
- CELLTRION, INC., KR
Prosecution history
- 04 Apr 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 07 Dec 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 18 Nov 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 18 Nov 2024 — FINAL DISPOSITION PROCESSED
- 04 Sept 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 04 Jun 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Jun 2024 — REGISTERED-PRINCIPAL REGISTER
- 19 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Mar 2024 — PUBLISHED FOR OPPOSITION
- 28 Feb 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Jan 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Jan 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 23 Jan 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 23 Jan 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED